Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | AV2A3 | — |
Ringing in ears; This non-serious case was reported by a other health professional via call center representative and described the occurrence of ringing in ears in a 69-year-old female patient who received HAB (Twinrix) (batch number AV2A3) for prophylaxis. On 08-OCT-2025, the patient received Twinrix. On 09-OCT-2025, 1 days after receiving Twinrix, the patient experienced ringing in ears (Verbatim: Ringing in ears). The outcome of the ringing in ears was not resolved. It was unknown if the reporter considered the ringing in ears to be related to Twinrix and Twinrix Pre-Filled Syringe Device. It was unknown if the company considered the ringing in ears to be related to Twinrix and Twinrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-OCT-2025 Pharmacy student reported that a patient had received a Twinrix injection on 8th October 2025. On the following day, she experienced ringing in the ears, which continued thereafter.